A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia
Introduction. Treatment of Haemophilus influenzae (Hi) pneumonia is on concern because resistance to amoxicillin is largely diffused. This study describes the evolution of resistance to amoxicillin and amoxicillin/clavulanic acid (AMC) in Hi isolates and characteristics of patients with Hi severe pn...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2020/2093468 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832560057497157632 |
|---|---|
| author | Pierre Danneels Maria Concetta Postorino Alessio Strazzulla Nabil Belfeki Aurelia Pitch Frank Pourcine Sebastien Jochmans Vincent Dubée Mehran Monchi Sylvain Diamantis |
| author_facet | Pierre Danneels Maria Concetta Postorino Alessio Strazzulla Nabil Belfeki Aurelia Pitch Frank Pourcine Sebastien Jochmans Vincent Dubée Mehran Monchi Sylvain Diamantis |
| author_sort | Pierre Danneels |
| collection | DOAJ |
| description | Introduction. Treatment of Haemophilus influenzae (Hi) pneumonia is on concern because resistance to amoxicillin is largely diffused. This study describes the evolution of resistance to amoxicillin and amoxicillin/clavulanic acid (AMC) in Hi isolates and characteristics of patients with Hi severe pneumonia. Methods. A monocentric retrospective observational study including patients from 2008 to 2017 with severe pneumonia hospitalized in ICU. Evolution of amoxicillin and AMC susceptibility was showed. Characteristics of patients with Hi pneumonia were compared to characteristics of patients with Streptococcus pneumoniae (Sp) pneumonia, as reference. Risk factors for amoxicillin resistance in Hi were investigated. Results. Overall, 113 patients with Hi and 132 with Sp pneumonia were included. The percentages of AMC resistance among Hi strains decreased over the years (from 10% in 2008-2009 to 0% in 2016-2017) while resistance to amoxicillin remained stable at 20%. Also, percentages of Sp resistant strains for amoxicillin decreased over years (from 25% to 3%). Patients with Hi pneumonia experienced higher prevalence of bronchitis (18% vs. 8%, p=0.02, chronic obstructive pulmonary disease (43% vs. 30% p=0.03), HAP (18% vs. 7%, p=0.01, ventilator-associated pneumonia (27% vs. 17%, p=0.04, and longer duration of mechanical ventilation (8 days vs. 6 days, p=0.04) than patients with Sp pneumonia. Patients with Sp pneumonia had more frequently local complications than patients with Hi pneumonia (17% vs. 7%, p=0.03). De-escalation of antibiotics was more frequent in patients with Sp than in patients with Hi (67% vs. 53%, p=0.03). No risk factors were associated with amoxicillin resistance among patients with Hi pneumonia. Conclusions. Amoxicillin resistance was stable over time, but no risk factors were detected. AMC resistance was extremely low, suggesting that AMC could be used for empiric treatment of Hi pneumonia, as well as other molecules, namely, cephalosporins. Patients with Hi pneumonia had more pulmonary comorbidities and severe diseases than patients with Sp pneumonia. |
| format | Article |
| id | doaj-art-b17b7d29382b45ec8df4c84170a81e5f |
| institution | Kabale University |
| issn | 1712-9532 1918-1493 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-b17b7d29382b45ec8df4c84170a81e5f2025-02-03T01:28:32ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932020-01-01202010.1155/2020/20934682093468A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae PneumoniaPierre Danneels0Maria Concetta Postorino1Alessio Strazzulla2Nabil Belfeki3Aurelia Pitch4Frank Pourcine5Sebastien Jochmans6Vincent Dubée7Mehran Monchi8Sylvain Diamantis9Infectious Diseases Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceInfectious Diseases Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceInfectious Diseases Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceInternal Medicine Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceMedical Biology Laboratory, Groupe Hospitalier Sud Ile de France, Melun, FranceIntensive Care Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceIntensive Care Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceCRCINA, Inserm, Paris, FranceIntensive Care Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceInfectious Diseases Unit, Groupe Hospitalier Sud Ile de France, Melun, FranceIntroduction. Treatment of Haemophilus influenzae (Hi) pneumonia is on concern because resistance to amoxicillin is largely diffused. This study describes the evolution of resistance to amoxicillin and amoxicillin/clavulanic acid (AMC) in Hi isolates and characteristics of patients with Hi severe pneumonia. Methods. A monocentric retrospective observational study including patients from 2008 to 2017 with severe pneumonia hospitalized in ICU. Evolution of amoxicillin and AMC susceptibility was showed. Characteristics of patients with Hi pneumonia were compared to characteristics of patients with Streptococcus pneumoniae (Sp) pneumonia, as reference. Risk factors for amoxicillin resistance in Hi were investigated. Results. Overall, 113 patients with Hi and 132 with Sp pneumonia were included. The percentages of AMC resistance among Hi strains decreased over the years (from 10% in 2008-2009 to 0% in 2016-2017) while resistance to amoxicillin remained stable at 20%. Also, percentages of Sp resistant strains for amoxicillin decreased over years (from 25% to 3%). Patients with Hi pneumonia experienced higher prevalence of bronchitis (18% vs. 8%, p=0.02, chronic obstructive pulmonary disease (43% vs. 30% p=0.03), HAP (18% vs. 7%, p=0.01, ventilator-associated pneumonia (27% vs. 17%, p=0.04, and longer duration of mechanical ventilation (8 days vs. 6 days, p=0.04) than patients with Sp pneumonia. Patients with Sp pneumonia had more frequently local complications than patients with Hi pneumonia (17% vs. 7%, p=0.03). De-escalation of antibiotics was more frequent in patients with Sp than in patients with Hi (67% vs. 53%, p=0.03). No risk factors were associated with amoxicillin resistance among patients with Hi pneumonia. Conclusions. Amoxicillin resistance was stable over time, but no risk factors were detected. AMC resistance was extremely low, suggesting that AMC could be used for empiric treatment of Hi pneumonia, as well as other molecules, namely, cephalosporins. Patients with Hi pneumonia had more pulmonary comorbidities and severe diseases than patients with Sp pneumonia.http://dx.doi.org/10.1155/2020/2093468 |
| spellingShingle | Pierre Danneels Maria Concetta Postorino Alessio Strazzulla Nabil Belfeki Aurelia Pitch Frank Pourcine Sebastien Jochmans Vincent Dubée Mehran Monchi Sylvain Diamantis A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia |
| title_full | A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia |
| title_fullStr | A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia |
| title_full_unstemmed | A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia |
| title_short | A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia |
| title_sort | retrospective study on amoxicillin susceptibility in severe haemophilus influenzae pneumonia |
| url | http://dx.doi.org/10.1155/2020/2093468 |
| work_keys_str_mv | AT pierredanneels aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT mariaconcettapostorino aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT alessiostrazzulla aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT nabilbelfeki aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT aureliapitch aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT frankpourcine aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT sebastienjochmans aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT vincentdubee aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT mehranmonchi aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT sylvaindiamantis aretrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT pierredanneels retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT mariaconcettapostorino retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT alessiostrazzulla retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT nabilbelfeki retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT aureliapitch retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT frankpourcine retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT sebastienjochmans retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT vincentdubee retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT mehranmonchi retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia AT sylvaindiamantis retrospectivestudyonamoxicillinsusceptibilityinseverehaemophilusinfluenzaepneumonia |